Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
Authors
Keywords
Anticancer immunity, Immune suppression, Immunotherapy, Pancreatic adenocarcinoma, CITIM 2013
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 63, Issue 1, Pages 59-65
Publisher
Springer Nature
Online
2013-10-15
DOI
10.1007/s00262-013-1485-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
- (2013) Alexandr V Bazhin et al. OncoImmunology
- The role of B7 family molecules in hematologic malignancy
- (2012) P. Greaves et al. BLOOD
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Current concepts and novel targets in advanced pancreatic cancer
- (2012) Patrick Michl et al. GUT
- Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
- (2012) Ivan Shevchenko et al. INTERNATIONAL JOURNAL OF CANCER
- Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
- (2012) Jan Schmidt et al. JOURNAL OF CLINICAL ONCOLOGY
- Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer
- (2012) Oliver Strobel et al. SURGERY
- Spontaneous regression of pancreatic cancer: Real or a misdiagnosis?
- (2012) Marta Herreros-Villanueva WORLD JOURNAL OF GASTROENTEROLOGY
- αLβ2 Integrin is indispensable for CD8+ T-cell recruitment in experimental pancreatic and hepatocellular cancer
- (2011) Takayuki Takeichi et al. INTERNATIONAL JOURNAL OF CANCER
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer
- (2011) Tomohisa Yamamoto et al. PANCREAS
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer
- (2010) A. Heller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma
- (2010) Collin Jacobs et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seromic profiling of ovarian and pancreatic cancer
- (2010) S. Gnjatic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials
- (2009) J P Neoptolemos et al. BRITISH JOURNAL OF CANCER
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Metastatic activity and chemotherapy resistance in human pancreatic cancer—influence of cancer stem cells
- (2009) Ivan Ischenko et al. SURGERY
- Immune Therapy for Cancer
- (2008) Michael Dougan et al. Annual Review of Immunology
- Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
- (2008) Martin Loos et al. CANCER LETTERS
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
- (2008) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More